Federico Angelo Cazzaniga,Edoardo Bistaffa,Chiara Maria Giulia De Luca,Sara Maria Portaleone,Marcella Catania,Veronica Redaelli,Irene Tramacere,Giuseppe Bufano,Martina Rossi,Paola Caroppo,Anna Rita Giovagnoli,Pietro Tiraboschi,Giuseppe Di Fede,Roberto Eleopra,Grazia Devigili,Antonio Emanuele Elia,Roberto Cilia,Michele Fiorini,Matilde Bongianni,Giulia Salzano,Luigi Celauro,Federico Giuseppe Quarta,Angela Mammana,Giuseppe Legname,Fabrizio Tagliavini,Piero Parchi,Gianluigi Zanusso,Giorgio Giaccone,Fabio Moda

Abstract:Sporadic Creutzfeldt-Jakob disease (sCJD) is a rare neurodegenerative disorder caused by the conformational conversion of the prion protein (PrP C ) into an abnormally folded form, named prion (or PrP Sc ). The combination of the polymorphism at codon 129 of the PrP gene (coding either methionine or valine) with the biochemical feature of the proteinase-K resistant PrP (generating either PrP Sc type 1 or 2) gives rise to different PrP Sc strains, which cause variable phenotypes of sCJD. The definitive diagnosis of sCJD and its classification can be achieved only post-mortem after PrP Sc identification and characterization in the brain. By exploiting the Real-Time Quaking-Induced Conversion (RT-QuIC) assay, traces of PrP Sc were found in the olfactory mucosa (OM) of sCJD patients, thus demonstrating that PrP Sc is not confined to the brain. Here, we have optimized another technique, named protein misfolding cyclic amplification (PMCA) for detecting PrP Sc in OM samples of sCJD patients. OM samples were collected from 27 sCJD and 2 genetic CJD patients (E200K). Samples from 34 patients with other neurodegenerative disorders were included as controls. Brains were collected from 26 sCJD patients and 16 of them underwent OM collection. Brain and OM samples were subjected to PMCA using the brains of transgenic mice expressing human PrP C with methionine at codon 129 as reaction substrates. The amplified products were analyzed by Western blot after proteinase K digestion. Quantitative PMCA was performed to estimate PrP Sc concentration in OM. PMCA enabled the detection of prions in OM samples with 79.3% sensitivity and 100% specificity. Except for a few cases, a predominant type 1 PrP Sc was generated, regardless of the tissues analyzed. Notably, all amplified PrP Sc were less resistant to PK compared to the original strain. In conclusion, although the optimized PMCA did not consent to recognize sCJD subtypes from the analysis of OM collected from living patients, it enabled us to estimate for the first time the amount of prions accumulating in this biological tissue. Further assay optimizations are needed to faithfully amplify peripheral prions whose recognition could lead to a better diagnosis and selection of patients for future clinical trials.

Monoclonal antibody against a peptide of human prion protein discriminates between Creutzfeldt-Jacob's disease-affected and normal brain tissue

Preparations of Specific Antibodies Against PrP N-terminal or C-terminal Peptides and Preliminary Study on Establishment of ELISA Diagnostic Method

Human Anti-prion Antibodies Block Prion Peptide Fibril Formation and Neurotoxicity

Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity

PrP(Sc)-specific Antibodies with the Ability to Immunodetect Prion Oligomers.

The Diversities of PrP(Sc) Distributions and Pathologic Changes in Various Brain Regions from a Chinese Patient with G114V Genetic CJD.

Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease

Characterization of variably protease-sensitive prionopathy by capillary electrophoresis

PrP Conformational Transitions Alter Species Preference of a PrP-specific Antibody

PMCA-Based Detection of Prions in the Olfactory Mucosa of Patients With Sporadic Creutzfeldt–Jakob Disease

All major prion types recognised by a multiplex immunofluorometric assay for disease screening and confirmation in sheep

Simple Method of Monoclonal Antibody Production Against Mammalian Cellular Prion Protein

Establishment of A Stable Prpsc Panel from Brain Tissues of Experimental Hamsters with Scrapie Strain 263K

Generation of Genetic Engineering Monoclonal Antibodies Against Prion Protein

Detection of Abnormal Prion Protein by Immunohistochemistry

Discrimination of Classical and Atypical BSE by a Distinct Immunohistochemical PrPSc Profile

The Prepared Tau Exon-Specific Antibodies Revealed Distinct Profiles of Tau in CSF of the Patients with Creutzfeldt-Jakob Disease.

Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification

Differentiation of ruminant transmissible spongiform encephalopathy isolate types, including bovine spongiform encephalopathy and CH1641 scrapie

Preparation of Monoclonal Antibodies Against Prion Proteins with Full-Length Hamster PrP.

Enhanced Creutzfeldt-Jakob disease surveillance in the older population: Assessment of a protocol for screening brain tissue donations for prion disease